Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
GERBER SCIENTIFIC INC (GRB)
|
Add to portfolio |
|
|
|
| Price: |
$10.91
| | Metrics |
| OS: |
22.3
|
M
| |
|
|
| Market cap: |
$244
|
M
| |
|
|
|
Net debt:
|
$10.2
|
M
| |
|
|
|
EV:
|
$254
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Apr-30-11 | Apr-30-10 | Apr-30-09 | Apr-30-08 | Apr-30-07 | Apr-30-06 | Apr-30-05 | Apr-30-04 |
| Revenues | 462.5 | 412.3 | 445.4 | 594.3 | 574.8 | 530.4 | 517.3 | 516.8 |
| Revenue growth | 12.2% | -7.4% | -25.1% | 3.4% | 8.4% | 2.5% | 0.1% | 0.9% |
| Cost of goods sold | 281.7 | 257.0 | 279.2 | 367.2 | 362.2 | 331.9 | 330.7 | 328.8 |
| Gross profit | 180.9 | 155.3 | 166.2 | 227.1 | 212.6 | 198.5 | 186.7 | 188.0 |
| Gross margin | 39.1% | 37.7% | 37.3% | 38.2% | 37.0% | 37.4% | 36.1% | 36.4% |
| Selling, general and administrative | 116.7 | 100.1 | 108.9 | 127.6 | 124.5 | 118.1 | 120.4 | 106.9 |
| Research and development | 16.0 | 14.9 | 17.3 | 26.2 | 24.3 | 24.9 | 25.0 | 25.2 |
| EBIT | 10.1 | 5.2 | 1.5 | 25.0 | 23.6 | 17.6 | 2.0 | 20.7 |
| EBIT margin | 2.2% | 1.3% | 0.3% | 4.2% | 4.1% | 3.3% | 0.4% | 4.0% |
| Pre-tax income | -6.4 | -1.6 | -4.2 | 21.2 | 20.6 | 9.2 | -10.1 | 0.7 |
| Income taxes | 0.3 | -0.7 | -5.7 | 6.0 | 7.1 | 6.2 | -4.4 | -3.9 |
| Tax rate | | 41.6% | 134.2% | 28.6% | 34.5% | 67.5% | 44.0% | |
| Earnings from continuing ops | -6.7 | -0.9 | 1.4 | 15.1 | 13.5 | 2.6 | -5.6 | 4.6 |
| Earnings from discontinued ops | -16.9 | -0.5 | 0.8 | -0.6 | | | | |
| Net income | -23.6 | -1.5 | 2.2 | 14.5 | 13.5 | 2.6 | -5.6 | 4.6 |
| Net margin | -5.1% | -0.4% | 0.5% | 2.4% | 2.4% | 0.5% | -1.1% | 0.9% |
| |
| Diluted EPS | ($0.27) | ($0.04) | $0.06 | $0.64 | $0.58 | $0.12 | ($0.25) | $0.20 |
| Shares outstanding (diluted) | 25.1 | 24.3 | 24.8 | 23.8 | 23.3 | 23.0 | 22.6 | 22.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|